scholarly journals Abstracts of poster presentations at the 2021 virtual annual of the Canadian Society for Pharmaceutical Sciences.

2021 ◽  
Vol 24 ◽  
Author(s):  
Kristine Warman

In 2021, the Canadian Society for Pharmaceutical Sciences (CSPS) partnered with he Pharmaceutical Society of Japan (PSJ) and the Canadian Chapter of Controlled Release Society (CC-CRS) and presented its annual matting in virtual style. Keynote speakers included Professor Michael Houghton – 2020 Nobel Laureate, Director of Li Ka Shing Applied Virology Institute (LKSAVI), Professor, Department of Medical Microbiology & Immunology, University of Alberta and Professor Yoshiharu Matsuura, Director, Center for Infectious Diseases Education and Research (CIDER), Osaka University, Japan.

2017 ◽  
Vol 20 (1) ◽  
pp. 332 ◽  
Author(s):  
Agnes Victoria Klein ◽  
Jian Wang ◽  
Brian G. Feagan ◽  
Mark Omoto

On May 12, 2017, various issues and challenges associated with biologics were discussed during a session of the annual joint conference of Canadian Society for Pharmaceutical Sciences and Canadian Chapter of Controlled Release Society at Hyatt Regency Hotel, Montréal, QC, Canada.  An update on the Canadian regulatory guidelines for biosimilars was given, followed by viewpoints expressed by regulatory, academic and industry scientists.  Topics of discussion included: reference biologic drug, clinical considerations, immunogenicity, extrapolation and clarification of terminology, product monograph, international collaboration, switching and interchangeability, naming conventions, clinical and non-clinical evaluation, authorization of indications, statistical equivalence, the nor-switch study and biologics marketplace.


2011 ◽  
Vol 52 (5) ◽  
pp. e103-e120 ◽  
Author(s):  
Kalpana Gupta ◽  
Thomas M. Hooton ◽  
Kurt G. Naber ◽  
Björn Wullt ◽  
Richard Colgan ◽  
...  

Abstract A Panel of International Experts was convened by the Infectious Diseases Society of America (IDSA) in collaboration with the European Society for Microbiology and Infectious Diseases (ESCMID) to update the 1999 Uncomplicated Urinary Tract Infection Guidelines by the IDSA. Co-sponsoring organizations include the American Congress of Obstetricians and Gynecologists, American Urological Association, Association of Medical Microbiology and Infectious Diseases–Canada, and the Society for Academic Emergency Medicine. The focus of this work is treatment of women with acute uncomplicated cystitis and pyelonephritis, diagnoses limited in these guidelines to premenopausal, non-pregnant women with no known urological abnormalities or co-morbidities. The issues of in vitro resistance prevalence and the ecological adverse effects of antimicrobial therapy (collateral damage) were considered as important factors in making optimal treatment choices and thus are reflected in the rankings of recommendations.


2021 ◽  
Vol 161 ◽  
pp. 66-79
Author(s):  
Namratha Turuvekere Vittala Murthy ◽  
Vibhuti Agrahari ◽  
Harsh Chauhan

2010 ◽  
Vol 85 (1) ◽  
pp. 19-22 ◽  
Author(s):  
Frederick Southwick ◽  
Peter Katona ◽  
Carol Kauffman ◽  
Sara Monroe ◽  
Liise-anne Pirofski ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document